Gliclazide and Co-codamol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gliclazide (gliclazide) and Co-codamol (acetaminophen; codeine phosphate). Common drug interactions include pulmonary oedema among females and jaundice among males.

The phase IV clinical study analyzes what interactions people have when they take Gliclazide and Co-codamol. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Co-codamol?

Co-codamol has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 2,364 Co-codamol users. Check the latest studies of Co-codamol.

On Jul, 18, 2026

64 people who take Gliclazide and Co-codamol together, and have interactions are studied.

Gliclazide and Co-codamol drug interactions.

What are the common drug interactions of Gliclazide and Co-Codamol, by gender? *:

female:

Pulmonary oedema (fluid accumulation in the lungs)
Swelling
Swelling face
Weight increased
Wheezing (a high-pitched whistling sound made while you breath)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac failure
Vomiting
Fall
Headache (pain in head)

male:

Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Nausea (feeling of having an urge to vomit)
Renal impairment (severely reduced kidney function)
Vomiting
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Gliclazide and Co-Codamol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Syncope (loss of consciousness with an inability to maintain postural tone)

50-59:

Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Cough
Diabetic microangiopathy (small blood vessels of the body are damaged due to diabetes)
Dizziness
Dyslipidaemia (abnormal amount of lipids)
Hypertension (high blood pressure)
Lower respiratory tract infection

60+:

Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Glomerular filtration rate decreased
Diabetes mellitus inadequate control
Lower respiratory tract infection
Pulmonary oedema (fluid accumulation in the lungs)
Vomiting
Dyspnoea (difficult or laboured respiration)
Fall
Headache (pain in head)
Hypersensitivity

What are the existing conditions these people have? *

Type 2 Diabetes: 20 people, 31.25%
High Blood Cholesterol: 13 people, 20.31%
High Blood Pressure: 7 people, 10.94%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 7.81%
Gastric Disorder (disease of stomach): 4 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and Co-codamol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously